BioNTECH解决了有关COVID-19疫苗使用费的专利纠纷,向NIH和Penn支付了1.26B美元。 BioNTech settles patent disputes over COVID-19 vaccine royalties, paying $1.26B to NIH and Penn.

Pfizer COVID-19疫苗的共同开发者BioNTECH与美国国家卫生研究所和宾夕法尼亚大学(宾夕法尼亚大学)解决了特许权使用费纠纷。 BioNTech, co-developer of the Pfizer COVID-19 vaccine, has settled disputes over royalties with the US National Institutes of Health (NIH) and the University of Pennsylvania (Penn). BioNTech将向NIH支付7.915亿美元,向Penn支付4.67亿美元。 BioNTech will pay $791.5 million to NIH and $467 million to Penn. Pfizer将向BioNTech公司偿还高达5.345亿美元的这些款项。 Pfizer will reimburse BioNTech up to $534.5 million of these payments. 这些解决方案包括今后使用所涉专利的许可证协议。 The settlements include license agreements for future use of the patents involved.